Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 12.60
Change Today -0.30 / -2.33%
Volume 106.4K
As of 6:51 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

nextgen biomed ltd (NXGN) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/30/14 - $40.00
52 Week Low
04/15/15 - $10.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEXTGEN BIOMED LTD (NXGN)

Related News

No related news articles were found.

nextgen biomed ltd (NXGN) Related Businessweek News

No Related Businessweek News Found

nextgen biomed ltd (NXGN) Details

Nextgen Biomed Ltd develops drugs for topical treatments for skin diseases. It develops DPS-101, a product that is in the Phase II/b used for the topical treatment of psoriasis without steroids. Nextgen Biomed Ltd has a collaboration agreement with the Boston VA Research Institute Inc. for the realization of Phase II and III of clinical experiments in human beings of DPS. The Company was incorporated in 1990 and is based in Tel Aviv, Israel.

Founded in 1990

nextgen biomed ltd (NXGN) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: 70.0K
Compensation as of Fiscal Year 2013.

nextgen biomed ltd (NXGN) Key Developments

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, Dec 22, 2014

Nextgen Biomed Ltd, Special/Extraordinary Shareholders Meeting, Dec 22, 2014., at 09:00 Israel Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXGN:IT 12.60 -0.30

NXGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NXGN.
View Industry Companies

Industry Analysis


Industry Average

Valuation NXGN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXTGEN BIOMED LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at